SLIMMING DRUGS
December 1st, 2002
BY KEITH NUTHALLTHE EUROPEAN Court of Justice has quashed a 2000 ban imposed by the European Commission on certain slimming drugs. Judges ruled that Brussels had exceeded its powers by withdrawing a 1996 marketing authorisation for products containing amphetamine-like anorectic agents (amfepramone, clobenzorex, fenproporex, norpseudoephedrine and phentermine). The court said that Brussels had acted on a changed interpretation of existing data, rather than on the facts. Companies involved included Artegodan, Bruno Farmaceutici, Schuck, Laboratórios Roussel, ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.